| Section | Status | CDF | Name |
| 08.03.04.02 | Formulary |  |
Abiraterone Zytiga® |
| 08.02.03 | Formulary | |
Atezolizumab Tecentriq® |
| 08.02.04 | Formulary | |
Axicabtagene ciloleucel YESCARTA® |
| 08.01.01 | Formulary | |
Bendamustine |
| 08.01.05 | Formulary | |
Bevacizumab |
| 08.01.05 | Formulary | |
Bortezomib Velcade® |
| 08.01.05 | Formulary | |
Brentuximab vedotin Adcetris® |
| 08.01.05 | Formulary | |
Cetuximab Erbitux® |
| 08.01.05 | Formulary | |
Daratumumab Darzalex ® |
| 08.01.05 | Formulary | |
Dasatinib Sprycel® |
| 08.01.02 | Formulary | |
Doxorubicin Hydrochloride Lipid formulation |
| 08.01.05 | Formulary | |
Ibrutinib Imbruvica® |
| 08.01.05 | Restricted Use | |
Ixazomib |
| 08.02.03 | Formulary | |
Nivolumab Opdivo® |
| 08.01.05 | Formulary | |
Osimertinib |
| 08.01.05 | Formulary | |
Panitumumab Vectibix® |
| 08.01.05 | Formulary | |
Pembrolizumab Keytruda® |
| 08.01.03 | Formulary | |
Pemetrexed Alimta® |
| 16.02 | Formulary | |
Radium-223 Xofigo® |
| 01.01 | Formulary | |
Remote Control Panasonic® |
| 08.01.05 | Formulary | |
Sorafenib Nexavar® |
| 08.01.05 | Formulary | |
Sunitinib Sutent® |
| 08.01.05 | Formulary | |
Temsirolimus Torisel® |
| 08.01.05 | Formulary | |
Tisagenlecleucel Kymriah® |
| 08.01.05 | Formulary | |
Venetoclax Venclyxto® |